Loading clinical trials...
Loading clinical trials...
Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Premenopausal Women at High Risk for Breast Cancer
Conditions
Interventions
celecoxib
placebo
Locations
9
United States
Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
Baylor University Medical Center - Houston
Houston, Texas, United States
Ben Taub General Hospital
Houston, Texas, United States
Methodist Hospital
Houston, Texas, United States
St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
Houston, Texas, United States
Start Date
November 1, 2004
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
August 10, 2018
NCT04541381
NCT05468034
NCT03137095
NCT07547774
NCT06393374
NCT04852887
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions